![]() |
|
|
Vol. 280, Issue 3, 1415-1422, 1997
Department of Pharmacology (K.H., M.S., J.S.P., J.S., S.C.),
University of Copenhagen, Copenhagen, Denmark and
Institute of
Pathology (N.M.), Randers Centralsygehus, Randers, Denmark
To test the hypothesis that the long-term antihypertensive action of
furosemide is mediated by a renomedullary vasodepressor substance, we
measured mean arterial pressure (MAP) by radiotelemetry in Dahl-S rats
with either intact or bromoethylamine-induced (BEA, 100 mg/kg i.p.)
lesion of the renal papilla and medulla. Seven days of recovery after
BEA administration, the rats diet was changed from 1 to 4% NaCl, and
during days 8 to 31, rats were randomized to daily treatment with
placebo or furosemide (50 mg/kg p.o.). Then furosemide treatment was
stopped and the rat food was changed to 1% NaCl diet. After a 10-day
wash-out period, renal function was measured. BEA produced a rapid
(within min) and sustained increase in MAP which was accelerated during
4% NaCl diet. Furosemide prevented 4% NaCl-induced hypertension in
both rats with intact kidneys and in rats with BEA-induced renal
papillary-medullary lesion. A significant decrease in renal plasma flow
(-34%) and glomerular filtration rate (-40%) was observed in all
BEA-treated rats independent of previous furosemide treatment. In
response to an i.v. load of isotonic saline (10% body weight), rats
with renal papillary-medullary lesion had an impaired ability to
excrete sodium. Histological examination showed that BEA-treated rats had severe lesions of the renal papilla and medulla, with
light-to-moderate changes in the renal cortex. It is concluded that the
antihypertensive effect of furosemide is not mediated by a
renomedullary vasodepressor substance. The accelerated NaCl-sensitive
hypertension in rats with BEA-induced renal papillary-medullary lesion
is related to an impaired ability to excrete excess NaCl.